close
MENU
3 mins to read

Is ResMed encroaching on F&P Healthcare's market share?

The close competitors don't like to give away market share but analysts delve deeper.

Calida Smylie
Mon, 02 May 2016

Medical device maker Fisher & Paykel Healthcare [NZX: FPH] looks to be holding strong against its main competitor for mask market share although its flow generator share has declined – but analysts have to keep a close watch to make sure.

East Tamaki-based F&P, which manufactures health products

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Calida Smylie
Mon, 02 May 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Is ResMed encroaching on F&P Healthcare's market share?
57740
true